Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 162

1.

Age-related decline in striatal dopamine transporter binding with iodine-123-beta-CITSPECT.

van Dyck CH, Seibyl JP, Malison RT, Laruelle M, Wallace E, Zoghbi SS, Zea-Ponce Y, Baldwin RM, Charney DS, Hoffer PB.

J Nucl Med. 1995 Jul;36(7):1175-81.

PMID:
7790941
[PubMed - indexed for MEDLINE]
Free Article
2.

Imaging serotonin and dopamine transporters with 123I-beta-CIT SPECT: binding kinetics and effects of normal aging.

Pirker W, Asenbaum S, Hauk M, Kandlhofer S, Tauscher J, Willeit M, Neumeister A, Praschak-Rieder N, Angelberger P, Brücke T.

J Nucl Med. 2000 Jan;41(1):36-44.

PMID:
10647603
[PubMed - indexed for MEDLINE]
Free Article
3.

Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients.

Seibyl JP, Marek K, Sheff K, Zoghbi S, Baldwin RM, Charney DS, van Dyck CH, Innis RB.

J Nucl Med. 1998 Sep;39(9):1500-8.

PMID:
9744331
[PubMed - indexed for MEDLINE]
Free Article
4.

Reproducibility of iodine-123-beta-CIT SPECT brain measurement of dopamine transporters.

Seibyl JP, Laruelle M, van Dyck CH, Wallace E, Baldwin RM, Zoghbi S, Zea-Ponce Y, Neumeyer JL, Charney DS, Hoffer PB, Innis RB.

J Nucl Med. 1996 Feb;37(2):222-8.

PMID:
8667048
[PubMed - indexed for MEDLINE]
Free Article
5.

Iodine-123-N-omega-fluoropropyl-2beta-carbomethoxy-3beta-(4-iod ophenyl)tropane SPECT in healthy controls and early-stage, drug-naive Parkinson's disease.

Tissingh G, Booij J, Bergmans P, Winogrodzka A, Janssen AG, van Royen EA, Stoof JC, Wolters EC.

J Nucl Med. 1998 Jul;39(7):1143-8.

PMID:
9669384
[PubMed - indexed for MEDLINE]
Free Article
6.

Test/retest reproducibility of iodine-123-betaCIT SPECT brain measurement of dopamine transporters in Parkinson's patients.

Seibyl JP, Marek K, Sheff K, Baldwin RM, Zoghbi S, Zea-Ponce Y, Charney DS, van Dyck CH, Hoffer PB, Innis RB.

J Nucl Med. 1997 Sep;38(9):1453-9.

PMID:
9293807
[PubMed - indexed for MEDLINE]
Free Article
7.

Comparative nigrostriatal dopaminergic imaging with iodine-123-beta CIT-FP/SPECT and fluorine-18-FDOPA/PET.

Ishikawa T, Dhawan V, Kazumata K, Chaly T, Mandel F, Neumeyer J, Margouleff C, Babchyck B, Zanzi I, Eidelberg D.

J Nucl Med. 1996 Nov;37(11):1760-5.

PMID:
8917170
[PubMed - indexed for MEDLINE]
Free Article
8.

SPECT-evaluation of the monoamine uptake site ligand [123I](1R)-2-beta-carbomethoxy-3-beta-(4-iodophenyl)-tropane ([123I]beta-CIT) in untreated patients with suspicion of Parkinson disease.

Eising EG, Müller TT, Zander C, Kuhn W, Farahati J, Reiners C, Coenen HH.

J Investig Med. 1997 Oct;45(8):448-52.

PMID:
9394097
[PubMed - indexed for MEDLINE]
9.

Sex differences in [123I]beta-CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers.

Staley JK, Krishnan-Sarin S, Zoghbi S, Tamagnan G, Fujita M, Seibyl JP, Maciejewski PK, O'Malley S, Innis RB.

Synapse. 2001 Sep 15;41(4):275-84.

PMID:
11494398
[PubMed - indexed for MEDLINE]
10.

[123I]beta-CIT single-photon emission tomography in Parkinson's disease reveals a smaller decline in dopamine transporters with age than in controls.

Tissingh G, Bergmans P, Booij J, Winogrodzka A, Stoof JC, Wolters EC, Van Royen EA.

Eur J Nucl Med. 1997 Sep;24(9):1171-4.

PMID:
9283113
[PubMed - indexed for MEDLINE]
11.

SPECT imaging of dopamine and serotonin transporters with [123I]beta-CIT: pharmacological characterization of brain uptake in nonhuman primates.

Laruelle M, Baldwin RM, Malison RT, Zea-Ponce Y, Zoghbi SS, al-Tikriti MS, Sybirska EH, Zimmermann RC, Wisniewski G, Neumeyer JL, et al.

Synapse. 1993 Apr;13(4):295-309.

PMID:
7683143
[PubMed - indexed for MEDLINE]
12.

Age-related decline in central serotonin transporter availability with [(123)I]beta-CIT SPECT.

van Dyck CH, Malison RT, Seibyl JP, Laruelle M, Klumpp H, Zoghbi SS, Baldwin RM, Innis RB.

Neurobiol Aging. 2000 Jul-Aug;21(4):497-501.

PMID:
10924762
[PubMed - indexed for MEDLINE]
13.

SPECT measurement of iodine-123-beta-CIT binding to dopamine and serotonin transporters in Parkinson's disease: correlation with symptom severity.

Kim SE, Lee WY, Choe YS, Kim JH.

Neurol Res. 1999 Apr;21(3):255-61.

PMID:
10319333
[PubMed - indexed for MEDLINE]
14.

Elevated striatal dopamine transporters during acute cocaine abstinence as measured by [123I] beta-CIT SPECT.

Malison RT, Best SE, van Dyck CH, McCance EF, Wallace EA, Laruelle M, Baldwin RM, Seibyl JP, Price LH, Kosten TR, Innis RB.

Am J Psychiatry. 1998 Jun;155(6):832-4.

PMID:
9619159
[PubMed - indexed for MEDLINE]
15.

Imaging of dopamine transporters with iodine-123-beta-CIT and SPECT in Parkinson's disease.

Asenbaum S, Brücke T, Pirker W, Podreka I, Angelberger P, Wenger S, Wöber C, Müller C, Deecke L.

J Nucl Med. 1997 Jan;38(1):1-6.

PMID:
8998140
[PubMed - indexed for MEDLINE]
Free Article
16.

Drug-naive patients with Parkinson's disease in Hoehn and Yahr stages I and II show a bilateral decrease in striatal dopamine transporters as revealed by [123I]beta-CIT SPECT.

Tissingh G, Bergmans P, Booij J, Winogrodzka A, van Royen EA, Stoof JC, Wolters EC.

J Neurol. 1998 Jan;245(1):14-20.

PMID:
9457623
[PubMed - indexed for MEDLINE]
17.

Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson disease.

Innis RB, Seibyl JP, Scanley BE, Laruelle M, Abi-Dargham A, Wallace E, Baldwin RM, Zea-Ponce Y, Zoghbi S, Wang S, et al.

Proc Natl Acad Sci U S A. 1993 Dec 15;90(24):11965-9.

PMID:
8265656
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

[123I]beta-CIT SPECT imaging of striatal dopamine transporter binding in Tourette's disorder.

Malison RT, McDougle CJ, van Dyck CH, Scahill L, Baldwin RM, Seibyl JP, Price LH, Leckman JF, Innis RB.

Am J Psychiatry. 1995 Sep;152(9):1359-61.

PMID:
7653693
[PubMed - indexed for MEDLINE]
19.

SPECT imaging of dopamine transporters in human brain with iodine-123-fluoroalkyl analogs of beta-CIT.

Abi-Dargham A, Gandelman MS, DeErausquin GA, Zea-Ponce Y, Zoghbi SS, Baldwin RM, Laruelle M, Charney DS, Hoffer PB, Neumeyer JL, Innis RB.

J Nucl Med. 1996 Jul;37(7):1129-33.

PMID:
8965183
[PubMed - indexed for MEDLINE]
Free Article
20.

The effect of dopamine agonist therapy on dopamine transporter imaging in Parkinson's disease.

Ahlskog JE, Uitti RJ, O'Connor MK, Maraganore DM, Matsumoto JY, Stark KF, Turk MF, Burnett OL.

Mov Disord. 1999 Nov;14(6):940-6.

PMID:
10584667
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk